DoeringW.Quinidine-digoxin interaction: Pharmacokinetics, underlying mechanisms, and clinical implications. N Engl J Med1979; 301: 400.
2.
WandellM, Effect of quinine on digoxin kinetics. Clin Pharmacol Ther1980; 28: 425.
3.
GilmanAGGoodmanLSGilmanA.Goodman and Gilman's the pharmacological basis of therapeutics. 6th ed.New York: Macmillan, 1980.
4.
UedaCT, Disposition kinetics of quinidine. Clin Pharmacol Ther1976; 19: 30.
5.
HagerWD, Digoxin quinidine interaction. N Engl J Med1979; 300: 1238.
6.
LigginsGCHowieRN. A controlled trial of antepartum glucocorticoid treatment for prevention of the respiratory distress syndrome in premature infants. Pediatrics1972; 50: 515.
7.
BardenT, Ritodrine hydrochloride: A betamimetic agent for use in preterm labor. Obstet Gynecol1980; 56: 1–12.
8.
ElliottHR. Pulmonary edema associated with ritodrine infusion and betamethasone administration in premature labor. Br Med J1978; 2: 799–800.
9.
TingaDJ. Post-partum pulmonary edema associated with preventive therapy for premature labor. Lancet1979; 1: 1026.
10.
JacobsMM. Maternal pulmonary edema resulting from betamimetic and glucocorticoid therapy. Obstet Gynecol1980; 56: 56–9.
11.
StubblefieldPG. Pulmonary edema occurring after therapy with dexamethasone and terbutaline for premature labor: A case report. Am J Obstet Gynecol1978; 56: 341–2.
12.
FairchildWVSpenceCRSolomonHD, The incidence of bladder cancer after cyclophosphamide therapy. J Urol1979; 122: 163–4.
13.
ChaskoSBKeuhnelianJGGutowskiWT, Spindle cell cancer of bladder during cyclophosphamide therapy for Wegener's granulomatosis. Am J Surg Pathol1980; 4: 191–6.
14.
PlotzPHKlippelJHDeckerJL, Bladder complications in patients receiving cyclophosphamide for systemic lupus erythematosus or rheumatoid arthritis. Ann Intern Med1979; 91: 221–3.
15.
DurkeeCBensonR.Bladder cancer following administration of cyclophosphamide. Urology1980; 16: 145–8.
16.
GlucksmanMA. Bladder cancer after cyclophosphamide therapy. Urology1980; 16: 553.
17.
GlucksmanMA. Cyclophosphamide therapy and oncogenic effect. Urology1981; 17: 218.
18.
ChodakGWStrausFWSchoenbergHW. Simultaneous occurrence of transitional, squamous and adenocarcinoma of the bladder after 15 years of cyclophosphamide ingestion. J Urol1981; 125: 424–6.
19.
CoxPJ. Cyclophosphamide cystitis and bladder cancer. A hypothesis. Eur J Cancer1979; 15: 1071–2.
20.
FuchsEFKayRPooleR, Uroepithelial carcinoma in association with cyclophosphamide ingestion. J Urol1981; 126: 544–5.
21.
GlucksmanMA. Cyclophosphamide therapy and oncogenic effect (letter). Urology1981; 17: 218.
22.
GarvinDDBallTP. Bladder malignancy in patients receiving cyclophosphamide for benign disease. Urology1981; 18: 80–1.
23.
GibsonRGGibsonSLMConwayVChappellD.Perna canaliculus in the treatment of arthritis. Practitioner1980; 224: 955–60.
24.
HuskissonECScottJBryansR.Seatone is ineffective in rheumatoid arthritis. Br Med J1981; 282: 1358–9.
25.
Green-lipped mussel extract in arthritis (editorial). Lancet1981; 1: 85.
26.
GibsonRGGibsonSLM. Green-lipped mussel extract in arthritis (letter). Lancet1981; 1: 439.
27.
GibsonRGGibsonSLM. Seatone in arthritis (letter). Br Med J1981; 282: 1795.